AUSTIN, Texas, Jan. 10, 2017 /PRNewswire/ -- ePatientFinder®, the leader in EHR-driven clinical trial site optimization and patient identification, and Allscripts® announce the release of GeoPrecise™, a comprehensive heatmap tool that redefines the way patient data is utilized for clinical trial site selection and patient identification.
GeoPrecise, a powerful patient identification and site feasibility analytics tool, enables clinical trial sponsors and contract research organizations (CROs) to tap into the powerful analytics of ePatientFinder's Clinical Trial Exchange™ platform and Allscripts' 45,000,000 unique electronic health records (EHRs) to pinpoint and enroll protocol-eligible patients in specific geographic regions across the country more quickly and efficiently than ever before.
"Increasingly, patient recruitment and big data companies are providing heatmaps aimed at helping sponsors and CROs identify the best locations to place their studies based on the theoretical number of patients in that area diagnosed with a specific medical condition or disease," said Tom Dorsett, CEO and President of ePatientFinder. "However, the problem is, they have no way of placing those specific patients into clinical trials."
For the first time ever, ePatientFinder's and Allscripts' GeoPrecise tool makes heatmaps actionable. "We're the only solution that is able to leverage big data sets, partner directly with physicians, and identify and enroll actual patients in clinical trials from those data sets," Dorsett said.
Other types of feasibility analytics and heatmap products only provide a visual representation of the geographic areas patients are located in using de-identified data. If a sponsor or CRO chooses a trial site based on that type of siloed data, they must then begin a completely separate process of identifying and enrolling trial participants.
"GeoPrecise, on the other hand, seamlessly combines the power of Allscripts' massive EHR data set with ePatientFinder's sophisticated algorithms, three-tier filtering process, and the trusted physician-patient relationship to match patients with clinical trials for advanced care," Dorsett explained.
ePatientFinder works directly with medical practices to assist physicians in identifying trial opportunities for protocol-eligible patients, creating a new revenue stream for providers.
"This innovative approach to clinical trial feasibility analytics and patient identification is a major breakthrough—not only for trial sponsors and CROs, but also for the providers that use the Allscripts EHR system and their patients," said Jay Bhattacharyya, Allscripts General Manager, Payer & Life Sciences. "Without GeoPrecise and eRecruit, fewer physicians—and their patients—would have access to potentially life-changing clinical trials."
ePatientFinder®, based in Austin, Texas, is the only company that provides physicians and clinical trial sites with a secure technology platform that allows them to compliantly leverage EHR data and make it actionable. By tapping into the trusted physician-patient relationship, ePatientFinder produces the highest quality referrals in the business, which in turn help clinical trials get populated more quickly and cost effectively than ever before. With ePatientFinder, physicians and EHR providers develop additional revenue streams with little change to their current activities, and patient satisfaction increases dramatically with access to the advanced care that is only available through clinical trials.
Amendola Communications for ePatientFinder:
Tara Stultz, 440.225.9595, tstultz@ACmarketingPR.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/epatientfinder-and-allscripts-launch-geoprecise-solution-a-game-changing-heatmap-tool-for-clinical-trial-site-selection-and-patient-identification-300388296.html